Brain magnetic resonance in hepatic encephalopathy

Seminars in Ultrasound, CT and MRI

Volumn 35, Issue 2, 2014, Pages 136-152

  Alonso, Juli ^a,b   Córdoba, Juan ^a,b,c   Rovira, Alex ^a,c  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MANGANESE;

ARTICLE; BASAL GANGLION; BRAIN NUCLEAR MAGNETIC RESONANCE; CARBON NUCLEAR MAGNETIC RESONANCE; DIFFUSION WEIGHTED IMAGING; DISEASE CLASSIFICATION; FLUID ATTENUATED INVERSION RECOVERY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HEPATIC ENCEPHALOPATHY; HUMAN; IMAGE ANALYSIS; NEUROIMAGING; NEUROTRANSMISSION; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOPHYSIOLOGY; PERFUSION WEIGHTED IMAGING; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RESTING STATE NETWORK; SYMPTOMATOLOGY; T1 WEIGHTED MAGNETIC RESONANCE IMAGING; T2 WEIGHTED MAGNETIC RESONANCE IMAGING; WHITE MATTER LESION; BRAIN; MYELINATED NERVE; PATHOLOGY; PROCEDURES; SYNDROME;

BRAIN; HEPATIC ENCEPHALOPATHY; HUMANS; MAGNETIC RESONANCE IMAGING; NERVE FIBERS, MYELINATED; PROTON MAGNETIC RESONANCE SPECTROSCOPY; SYNDROME;

EID: 84898681947     PISSN: 08872171     EISSN: 15585034     Source Type: Journal    
DOI: 10.1053/j.sult.2013.09.008     Document Type: Article

References (161)

1. Ferenci P., Lockwood A., Mullen K., et al. Hepatic encephalopathy-Definition, nomenclature, diagnosis, and quantification: Final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002, 35:716-721.
2. Prakash R., Mullen K.D. Mechanisms, diagnosis and management of hepatic encephalopathy. Nat Rev Gastroenterol Hepatol 2010, 7:515-525.
3. Weissenborn K. Diagnosis of encephalopathy. Digestion 1998, 59(suppl 2):22-24.
4. Blei A.T., Córdoba J. Hepatic encephalopathy. Am J Gastroenterol 2001, 96:1968-1976.
5. Cadranel J.F., Lebiez E., Di Martino V., et al. Focal neurological signs in hepatic encephalopathy in cirrhotic patients: An underestimated entity?. Am J Gastroenterol 2001, 96:515-518.
6. Joebges E.M., Heidemann M., Schimke N., et al. Bradykinesia in minimal hepatic encephalopathy is due to disturbances in movement initiation. J Hepatol 2003, 38:273-280.
7. Lewis M., Howdle P.D. The neurology of liver failure. QJM 2003, 96:623-633.
8. Butterworth R.F. Neuroinflammation in acute liver failure: Mechanisms and novel therapeutic targets. Neurochem Int 2011, 59:830-836.
9. Cordoba J., Minguez B. Hepatic encephalopathy. Semin Liver Dis 2008, 28:70-80.
10. Häussinger D., Schliess F. Pathogenetic mechanisms of hepatic encephalopathy. Gut 2008, 57:1156-1165.
11. Jones E.A., Mullen K.D. Theories of the pathogenesis of hepatic encephalopathy. Clin Liver Dis 2012, 16:7-26.
12. Khungar V., Poordad F. Hepatic encephalopathy. Clin Liver Dis 2012, 16:301-320.
13. McPhail M.J.W., Bajaj J.S., Thomas H.C., et al. Pathogenesis and diagnosis of hepatic encephalopathy. Expert Rev Gastroenterol Hepatol 2010, 4:365-378.
14. Inoue E., Hori S., Narumi Y., et al. Portal-systemic encephalopathy: Presence of basal ganglia lesions with high signal intensity on MR images. Radiology 1991, 179:551-555.
15. Pujol A., Pujol J., Graus F., et al. Hyperintense globus pallidus on T1-weighted MRI in cirrhotic patients is associated with severity of liver failure. Neurology 1993, 43:65-69.
16. Zeneroli M.L., Cioni G., Crisi G., et al. Globus pallidus alterations and brain atrophy in liver cirrhosis patients with encephalopathy: An MR imaging study. Magn Reson Imaging 1991, 9:295-302.
17. Córdoba J., Olivé G., Alonso J., et al. Improvement of magnetic resonance spectroscopic abnormalities but not pallidal hyperintensity followed amelioration of hepatic encephalopathy after occlusion of a large spleno-renal shunt. J Hepatol 2001, 34:176-178.
18. Córdoba J., Alonso J., Rovira A., et al. The development of low-grade cerebral edema in cirrhosis is supported by the evolution of (1)H-magnetic resonance abnormalities after liver transplantation. J Hepatol 2001, 35:598-604.
19. Naegele T., Grodd W., Viebahn R., et al. MR imaging and (1)H spectroscopy of brain metabolites in hepatic encephalopathy: Time-course of renormalization after liver transplantation. Radiology 2000, 216:683-691.
20. Watanabe A., Murakami J., Ando T., et al. Reduction of increased signal intensity in the basal ganglia on T1-weighted MR images during treatment of hepatic encephalopathy. Intern Med 1993, 32:10-14.
21. Weissenborn K., Ehrenheim C., Hori A., et al. Pallidal lesions in patients with liver cirrhosis: Clinical and MRI evaluation. Metab Brain Dis 1995, 10:219-231.
22. Nolte W., Wiltfang J., Schindler C.G., et al. Bright basal ganglia in T1-weighted magnetic resonance images are frequent in patients with portal vein thrombosis without liver cirrhosis and not suggestive of hepatic encephalopathy. J Hepatol 1998, 29:443-449.
23. Goel A., Yadav S., Saraswat V., et al. Cerebral oedema in minimal hepatic encephalopathy due to extrahepatic portal venous obstruction. Liver Int 2010, 30:1143-1151.
24. Mínguez B., García-Pagán J.C., Bosch J., et al. Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy. Hepatology 2006, 43:707-714.
25. Yadav S.K., Srivastava A., Srivastava A., et al. Encephalopathy assessment in children with extra-hepatic portal vein obstruction with MR, psychometry and critical flicker frequency. J Hepatol 2010, 52:348-354.
26. Fukuzawa T., Matsutani S., Maruyama H., et al. Magnetic resonance images of the globus pallidus in patients with idiopathic portal hypertension: A quantitative analysis of the relationship between signal intensity and the grade of portosystemic shunt. J Gastroenterol Hepatol 2006, 21:902-907.
27. Das K., Singh P., Chawla Y., et al. Magnetic resonance imaging of brain in patients with cirrhotic and non-cirrhotic portal hypertension. Dig Dis Sci 2008, 53:2793-2798.
28. Krieger S., Jauss M., Jansen O., et al. MRI findings in chronic hepatic encephalopathy depend on portosystemic shunt: Results of a controlled prospective clinical investigation. J Hepatol 1997, 27:121-126.
29. Matsumoto S., Mori H., Yoshioka K., et al. Effects of portal-systemic shunt embolization on the basal ganglia: MRI. Neuroradiology 1997, 39:326-328.
30. 1H MR spectroscopy of the brain in patients with liver cirrhosis and early stages of hepatic encephalopathy. Hepatogastroenterology 2003, 50:2149-2153.
31. Binesh N., Huda A., Thomas M.A., et al. Hepatic encephalopathy: A neurochemical, neuroanatomical, and neuropsychological study. J Appl Clin Med Phys 2006, 7:86-96.
32. Geissler A., Lock G., Fründ R., et al. Cerebral abnormalities in patients with cirrhosis detected by proton magnetic resonance spectroscopy and magnetic resonance imaging. Hepatology 1997, 25:48-54.
33. Krieger S., Jauss M., Jansen O., et al. Neuropsychiatric profile and hyperintense globus pallidus on T1-weighted magnetic resonance images in liver cirrhosis. Gastroenterology 1996, 111:147-155.
34. Taylor-Robinson S.D., Oatridge A., Hajnal J.V., et al. MR imaging of the basal ganglia in chronic liver disease: Correlation of T1-weighted and magnetisation transfer contrast measurements with liver dysfunction and neuropsychiatric status. Metab Brain Dis 1995, 10:175-188.
35. Thuluvath P.J., Edwin D., Yue N.C., et al. Increased signals seen in globus pallidus in T1-weighted magnetic resonance imaging in cirrhotics are not suggestive of chronic hepatic encephalopathy. Hepatology 1995, 21:440-442.
36. Spahr L., Vingerhoets F., Lazeyras F., et al. Magnetic resonance imaging and proton spectroscopic alterations correlate with parkinsonian signs in patients with cirrhosis. Gastroenterology 2000, 119:774-781.
37. 1H spectroscopic findings. Am J Neuroradiol 2004, 25:1247-1250.
38. Norton N.S., McConnell J.R., Zetterman R.K., et al. A quantitative evaluation of magnetic resonance image signal changes of the brain in chronic hepatic encephalopathy. J Hepatol 1994, 21:764-770.
39. Butterworth R.F., Spahr L., Fontaine S., et al. Manganese toxicity, dopaminergic dysfunction and hepatic encephalopathy. Metab Brain Dis 1995, 10:259-267.
40. Krieger D., Krieger S., Jansen O., et al. Manganese and chronic hepatic encephalopathy. Lancet 1995, 346:270-274.
41. Maeda H., Sato M., Yoshikawa A., et al. Brain MR imaging in patients with hepatic cirrhosis: Relationship between high intensity signal in basal ganglia on T1-weighted images and elemental concentrations in brain. Neuroradiology 1997, 39:546-550.
42. Ejima A., Imamura T., Nakamura S., et al. Manganese intoxication during total parenteral nutrition. Lancet 1992, 339:426.
43. Josephs K.A., Ahlskog J.E., Klos K.J., et al. Neurologic manifestations in welders with pallidal MRI T1 hyperintensity. Neurology 2005, 64:2033-2039.
44. Mirowitz S.A., Westrich T.J. Basal ganglial signal intensity alterations: Reversal after discontinuation of parenteral manganese administration. Radiology 1992, 185:535-536.
45. Chen H., Wang Y., Zhu X., et al. White matter abnormalities correlate with neurocognitive performance in patients with HBV-related cirrhosis. J Neurol Sci 2012, 321:65-72.
46. Montoliu C., Gonzalez-Escamilla G., Atienza M., et al. Focal cortical damage parallels cognitive impairment in minimal hepatic encephalopathy. Neuroimage 2012, 61:1165-1175.
47. Garcia-Martinez R., Rovira A., Alonso J., et al. Hepatic encephalopathy is associated with posttransplant cognitive function and brain volume. Liver Transpl 2011, 17:38-46.
48. Guevara M., Baccaro M.E., Gómez-Ansón B., et al. Cerebral magnetic resonance imaging reveals marked abnormalities of brain tissue density in patients with cirrhosis without overt hepatic encephalopathy. J Hepatol 2011, 55:564-573.
49. Rovira A., Grivé E., Pedraza S., et al. Magnetization transfer ratio values and proton MR spectroscopy of normal-appearing cerebral white matter in patients with liver cirrhosis. Am J Neuroradiol 2001, 22:1137-1142.
50. Poveda M., Bernabeu A., Concepción L., et al. Brain edema dynamics in patients with overt hepatic encephalopathy: A magnetic resonance imaging study. Neuroimage 2010, 52:481-487.
51. Iwasa M., Kinosada Y., Nakatsuka A., et al. Magnetization transfer contrast of various regions of the brain in liver cirrhosis. Am J Neuroradiol 1999, 20:652-654.
52. Miese F., Wittsack H., Kircheis G., et al. Voxel-based analyses of magnetization transfer imaging of the brain in hepatic encephalopathy. World J Gastroenterol 2009, 15:5157-5164.
53. 1H-MR spectroscopy, magnetization transfer, and diffusion-weighted imaging in alcoholic and nonalcoholic patients with cirrhosis with hepatic encephalopathy. Am J Neuroradiol 2006, 27:1019-1026.
54. Balata S., Damink S.W.M.O., Ferguson K., et al. Induced hyperammonemia alters neuropsychology, brain MR spectroscopy and magnetization transfer in cirrhosis. Hepatology 2003, 37:931-939.
55. Cucurella M.G., Rovira A., Grivé E., et al. Serial proton spectroscopy, magnetization transfer ratio and T2 relaxation in pseudotumoral demyelinating lesions. NMR Biomed 2002, 15:284-292.
56. Dousset V., Grossman R.I., Ramer K.N., et al. Experimental allergic encephalomyelitis and multiple sclerosis: Lesion characterization with magnetization transfer imaging. Radiology 1992, 182:483-491.
57. Rovira A., Alonso J., Cucurella G., et al. Evolution of multiple sclerosis lesions on serial contrast-enhanced T1-weighted and magnetization-transfer MR images. Am J Neuroradiol 1999, 20:1939-1945.
58. Häussinger D., Kircheis G., Fischer R., et al. Hepatic encephalopathy in chronic liver disease: A clinical manifestation of astrocyte swelling and low-grade cerebral edema?. J Hepatol 2000, 32:1035-1038.
59. Rovira A., Córdoba J., Sanpedro F., et al. Normalization of T2 signal abnormalities in hemispheric white matter with liver transplant. Neurology 2002, 59:335-341.
60. Lee Y.C., Markus R., Hughes A. MRI in ALS: Corticospinal tract hyperintensity. Neurology 2003, 61:1600.
61. Córdoba J., Raguer N., Flavià M., et al. T2 hyperintensity along the cortico-spinal tract in cirrhosis relates to functional abnormalities. Hepatology 2003, 38:1026-1033.
62. Rydberg J.N., Hammond C.A., Grimm R.C., et al. Initial clinical experience in MR imaging of the brain with a fast fluid-attenuated inversion-recovery pulse sequence. Radiology 1994, 193:173-180.
63. Gawne-Cain M.L., Silver N.C., Moseley I.F., et al. Fast FLAIR of the brain: The range of appearances in normal subjects and its application to quantification of white-matter disease. Neuroradiology 1997, 39:243-249.
64. 1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis. Neuroradiology 2001, 43:189-197.
65. Rao K.V., Norenberg M.D. Cerebral energy metabolism in hepatic encephalopathy and hyperammonemia. Metab Brain Dis 2001, 16:67-78.
66. Zhou B.G., Norenberg M.D. Ammonia downregulates GLAST mRNA glutamate transporter in rat astrocyte cultures. Neurosci Lett 1999, 276:145-148.
67. Ito S., Sakakibara R., Yoshiyama Y., et al. Senile portosystemic hepatic encephalopathy as a treatable dementia-like syndrome. J Neurol 2004, 251:1015-1016.
68. Matsusue E., Kinoshita T., Ohama E., et al. Cerebral cortical and white matter lesions in chronic hepatic encephalopathy: MR-pathologic correlations. Am J Neuroradiol 2005, 26:347-351.
69. Mínguez B., Rovira A., Alonso J., et al. Decrease in the volume of white matter lesions with improvement of hepatic encephalopathy. Am J Neuroradiol 2007, 28:1499-1500.
70. Rovira A., Mínguez B., Aymerich F.X., et al. Decreased white matter lesion volume and improved cognitive function after liver transplantation. Hepatology 2007, 46:1485-1490.
71. de Leeuw F.E., de Groot J.C., Achten E., et al. Prevalence of cerebral white matter lesions in elderly people: A population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry 2001, 70:9-14.
72. Schmidt R., Enzinger C., Ropele S., et al. Progression of cerebral white matter lesions: 6-Year results of the Austrian Stroke Prevention Study. Lancet 2003, 361:2046-2048.
73. Taylor W.D., MacFall J.R., Provenzale J.M., et al. Serial MR imaging of volumes of hyperintense white matter lesions in elderly patients: Correlation with vascular risk factors. Am J Roentgenol 2003, 181:571-576.
74. Ziylan Y.Z., Uzüm G., Bernard G., et al. Changes in the permeability of the blood-brain barrier in acute hyperammonemia. Effect of dexamethasone. Mol Chem Neuropathol 1993, 20:203-218.
75. McKinney A.M., Lohman B.D., Sarikaya B., et al. Acute hepatic encephalopathy: Diffusion-weighted and fluid-attenuated inversion recovery findings, and correlation with plasma ammonia level and clinical outcome. Am J Neuroradiol 2010, 31:1471-1479.
76. Kim H.K., Lee H.J., Lee W., et al. Pattern approach to MR imaging in patients with end-stage hepatic failure: A proposal for a new disease entity "hepatic encephalopathy continuum". Neuroradiology 2008, 50:683-691.
77. Singhal A., Nagarajan R., Kumar R., et al. Magnetic resonance T2-relaxometry and 2D L-correlated spectroscopy in patients with minimal hepatic encephalopathy. J Magn Reson Imaging 2009, 30:1034-1041.
78. Shah N.J., Neeb H., Kircheis G., et al. Quantitative cerebral water content mapping in hepatic encephalopathy. Neuroimage 2008, 41:706-717.
79. Schaefer P.W., Grant P.E., Gonzalez R.G. Diffusion-weighted MR imaging of the brain. Radiology 2000, 217:331-345.
80. Chavarria L., Alonso J., García-Martínez R., et al. Brain magnetic resonance spectroscopy in episodic hepatic encephalopathy. J Cereb Blood Flow Metab 2013, 33:272-277.
81. Kale R.A., Gupta R.K., Saraswat V.A., et al. Demonstration of interstitial cerebral edema with diffusion tensor MR imaging in type C hepatic encephalopathy. Hepatology 2006, 43:698-706.
82. Kumar R., Gupta R.K., Elderkin-Thompson V., et al. Voxel-based diffusion tensor magnetic resonance imaging evaluation of low-grade hepatic encephalopathy. J Magn Reson Imaging 2008, 27:1061-1068.
83. Lodi R., Tonon C., Stracciari A., et al. Diffusion MRI shows increased water apparent diffusion coefficient in the brains of cirrhotics. Neurology 2004, 62:762-766.
84. Qi R., Xu Q., Zhang L.J., et al. Structural and functional abnormalities of default mode network in minimal hepatic encephalopathy: A study combining DTI and fMRI. PLoS ONE 2012, 7:e41376.
85. Srivastava A., Yadav S.K., Lal R., et al. Effect of surgical portosystemic shunt on prevalence of minimal hepatic encephalopathy in children with extrahepatic portal venous obstruction: Assessment by magnetic resonance imaging and psychometry. J Pediatr Gastroenterol Nutr 2010, 51:766-772.
86. Srivastava A., Yadav S.K., Yachha S.K., et al. Pro-inflammatory cytokines are raised in extrahepatic portal venous obstruction, with minimal hepatic encephalopathy. J Gastroenterol Hepatol 2011, 26:979-986.
87. Sugimoto R., Iwasa M., Maeda M., et al. Value of the apparent diffusion coefficient for quantification of low-grade hepatic encephalopathy. Am J Gastroenterol 2008, 103:1413-1420.
88. 1H-MR spectroscopy changes in patients with extrahepatic portal vein obstruction from early childhood to adulthood. Am J Neuroradiol 2010, 31:1337-1342.
89. Mardini H., Smith F.E., Record C.O., et al. Magnetic resonance quantification of water and metabolites in the brain of cirrhotics following induced hyperammonaemia. J Hepatol 2011, 54:1154-1160.
90. Gupta R.K., Yadav S.K., Rangan M., et al. Serum proinflammatory cytokines correlate with diffusion tensor imaging derived metrics and (1)H-MR spectroscopy in patients with acute liver failure. Metab Brain Dis 2010, 25:355-361.
91. Ranjan P., Mishra A.M., Kale R., et al. Cytotoxic edema is responsible for raised intracranial pressure in fulminant hepatic failure: In vivo demonstration using diffusion-weighted MRI in human subjects. Metab Brain Dis 2005, 20:181-192.
92. Saksena S., Rai V., Saraswat V.A., et al. Cerebral diffusion tensor imaging and in vivo proton magnetic resonance spectroscopy in patients with fulminant hepatic failure. J Gastroenterol Hepatol 2008, 23:e111-e119.
93. Srivastava A., Yadav S.K., Borkar V.V., et al. Serial evaluation of children with ALF with advanced MRI, serum proinflammatory cytokines, thiamine, and cognition assessment. J Pediatr Gastroenterol Nutr 2012, 55:580-586.
94. Blei A.T. Infection, inflammation and hepatic encephalopathy, synergism redefined. J Hepatol 2004, 40:327-330.
95. Cauli O., Rodrigo R., Piedrafita B., et al. Inflammation and hepatic encephalopathy: Ibuprofen restores learning ability in rats with portacaval shunts. Hepatology 2007, 46:514-519.
96. Rai V., Nath K., Saraswat V.A., et al. Measurement of cytotoxic and interstitial components of cerebral edema in acute hepatic failure by diffusion tensor imaging. J Magn Reson Imaging 2008, 28:334-341.
97. Nath K., Saraswat V.A., Krishna Y.R., et al. Quantification of cerebral edema on diffusion tensor imaging in acute-on-chronic liver failure. NMR Biomed 2008, 21:713-722.
98. Brugières P., Thomas P., Maraval A., et al. Water diffusion compartmentation at high b values in ischemic human brain. Am J Neuroradiol 2004, 25:692-698.
99. Schwarcz A., Ursprung Z., Berente Z., et al. In vivo brain edema classification: New insight offered by large b-value diffusion-weighted MR imaging. J Magn Reson Imaging 2007, 25:26-31.
100. Chavarria L., Alonso J., García-Martínez R., et al. Biexponential analysis of diffusion-tensor imaging of the brain in patients with cirrhosis before and after liver transplantation. Am J Neuroradiol 2011, 32:1510-1517.
101. Hazell A.S., Normandin L., Norenberg M.D., et al. Alzheimer type II astrocytic changes following sub-acute exposure to manganese and its prevention by antioxidant treatment. Neurosci Lett 2006, 396:167-171.
102. Eng L.F., Ghirnikar R.S., Lee Y.L. Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochem Res 2000, 25:1439-1451.
103. Chen K.C., Nicholson C. Changes in brain cell shape create residual extracellular space volume and explain tortuosity behavior during osmotic challenge. Proc Natl Acad Sci U S A 2000, 97:8306-8311.
104. Chavarria L., Oria M., Romero-Gimenez J., et al. Diffusion tensor imaging supports the cytotoxic origin of brain edema in a rat model of acute liver failure. Gastroenterology 2010, 138:1566-1573.
105. Cordoba J., Blei A.T. Brain edema and hepatic encephalopathy. Semin Liver Dis 1996, 16:271-280.
106. Kircheis G., Wettstein M., Timmermann L., et al. Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology 2002, 35:357-366.
107. Zafiris O., Kircheis G., Rood H.A., et al. Neural mechanism underlying impaired visual judgement in the dysmetabolic brain: An fMRI study. Neuroimage 2004, 22:541-552.
108. Liao L., Zhou L., Le H., et al. Spatial working memory dysfunction in minimal hepatic encephalopathy: An ethology and BOLD-fMRI study. Brain Res 2012, 1445:62-72.
109. Chen H., Zhu X., Yang M., et al. Changes in the regional homogeneity of resting-state brain activity in minimal hepatic encephalopathy. Neurosci Lett 2012, 507:5-9.
110. Chen H., Zhu X., Jiao Y., et al. Abnormal baseline brain activity in low-grade hepatic encephalopathy: A resting-state fMRI study. J Neurol Sci 2012, 318:140-145.
111. Qi R., Zhang L.J., Xu Q., et al. Selective impairments of resting-state networks in minimal hepatic encephalopathy. PLoS ONE 2012, 7:e37400.
112. Zhang L.J., Zheng G., Zhang L., et al. Altered brain functional connectivity in patients with cirrhosis and minimal hepatic encephalopathy: A functional MR imaging study. Radiology 2012, 265:528-536.
113. Ni L., Qi R., Zhang L.J., et al. Altered regional homogeneity in the development of minimal hepatic encephalopathy: A resting-state functional MRI study. PLoS ONE 2012, 7:e42016.
114. Zhang L., Qi R., Wu S., et al. Brain default-mode network abnormalities in hepatic encephalopathy: A resting-state functional MRI study. Hum Brain Mapp 2012, 33:1384-1392.
115. Qi R., Zhang L., Wu S., et al. Altered resting-state brain activity at functional MR imaging during the progression of hepatic encephalopathy. Radiology 2012, 264:187-195.
116. Hsu T., Wu C.W., Cheng Y., et al. Impaired small-world network efficiency and dynamic functional distribution in patients with cirrhosis. PLoS ONE 2012, 7:e35266.
117. Chen H., Jiao Y., Zhu X., et al. Brain dysfunction primarily related to previous overt hepatic encephalopathy compared with minimal hepatic encephalopathy: Resting-state functional MR imaging demonstration. Radiology 2013, 266:261-270.
118. Lin W., Hsu T., Chen C., et al. Connectivity of default-mode network is associated with cerebral edema in hepatic encephalopathy. PLoS ONE 2012, 7:e36986.
119. Cha S. Perfusion MR imaging: Basic principles and clinical applications. Magn Reson Imaging Clin N Am 2003, 11:403-413.
120. Detre J.A., Rao H., Wang D.J.J., et al. Applications of arterial spin labeled MRI in the brain. J Magn Reson Imaging 2012, 35:1026-1037.
121. Li T., Li X., Zhou W., et al. Dynamic susceptibility contrast-enhanced first-pass perfusion MR imaging in patients with subclinical hepatic encephalopathy. J Neuroradiol 2012, 39:290-294.
122. Zheng G., Zhang L.J., Wang Z., et al. Changes in cerebral blood flow after transjugular intrahepatic portosystemic shunt can help predict the development of hepatic encephalopathy: An arterial spin labeling MR study. Eur J Radiol 2012, 81:3851-3856.
123. Kreis R., Farrow N., Ross B.D. Diagnosis of hepatic encephalopathy by proton magnetic resonance spectroscopy. Lancet 1990, 336:635-636.
124. Kreis R., Ross B.D., Farrow N.A., et al. Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology 1992, 182:19-27.
125. Catafau A.M., Kulisevsky J., Bernà L., et al. Relationship between cerebral perfusion in frontal-limbic-basal ganglia circuits and neuropsychologic impairment in patients with subclinical hepatic encephalopathy. J Nucl Med 2000, 41:405-410.
126. Haseler L.J., Sibbitt W.L.J., Mojtahedzadeh H.N., et al. Proton MR spectroscopic measurement of neurometabolites in hepatic encephalopathy during oral lactulose therapy. Am J Neuroradiol 1998, 19:1681-1686.
127. Häussinger D., Laubenberger J., vom Dahl S., et al. Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy. Gastroenterology 1994, 107:1475-1480.
128. Mechtcheriakov S., Schocke M., Kugener A., et al. Chemical shift magnetic resonance spectroscopy of cingulate grey matter in patients with minimal hepatic encephalopathy. Neuroradiology 2005, 47:27-34.
129. 1H MR spectroscopy and neuropsychologic status of patients with hepatic encephalopathy. Am J Roentgenol 1998, 171:1123-1130.
130. 1H magnetic resonance spectroscopy in hepatic encephalopathy. Psychosom Med 1998, 60:550-556.
131. Bajaj J.S., Gillevet P.M., Patel N.R., et al. A longitudinal systems biology analysis of lactulose withdrawal in hepatic encephalopathy. Metab Brain Dis 2012, 27:205-215.
132. Delcker A., Turowski B., Mihm U., et al. Proton MR spectroscopy of neurometabolites in hepatic encephalopathy during l-ornithine-l-aspartate treatment-Results of a pilot study. Metab Brain Dis 2002, 17:103-111.
133. Shawcross D.L., Balata S., Olde Damink S.W.M., et al. Low myo-inositol and high glutamine levels in brain are associated with neuropsychological deterioration after induced hyperammonemia. Am J Physiol Gastrointest Liver Physiol 2004, 287:G503-G509.
134. Guevara M., Baccaro M.E., Torre A., et al. Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: A prospective study with time-dependent analysis. Am J Gastroenterol 2009, 104:1382-1389.
135. Ross B.D., Jacobson S., Villamil F., et al. Subclinical hepatic encephalopathy: Proton MR spectroscopic abnormalities. Radiology 1994, 193:457-463.
136. Laubenberger J., Häussinger D., Bayer S., et al. Proton magnetic resonance spectroscopy of the brain in symptomatic and asymptomatic patients with liver cirrhosis. Gastroenterology 1997, 112:1610-1616.
137. Pujol J., Kulisevsky J., Moreno A., et al. Neurospectroscopic alterations and globus pallidus hyperintensity as related magnetic resonance markers of reversible hepatic encephalopathy. Neurology 1996, 47:1526-1530.
138. Taylor-Robinson S.D., Sargentoni J., Marcus C.D., et al. Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathy. Metab Brain Dis 1994, 9:347-359.
139. Weissenborn K., Ahl B., Fischer-Wasels D., et al. Correlations between magnetic resonance spectroscopy alterations and cerebral ammonia and glucose metabolism in cirrhotic patients with and without hepatic encephalopathy. Gut 2007, 56:1736-1742.
140. 1H-MRS) findings for the brain in patients with liver cirrhosis reflect the hepatic functional reserve. Am J Gastroenterol 1999, 94:2206-2213.
141. Hamuro M., Nakamura K., Matsuoka T., et al. Proton MR spectroscopy of the brain in patients treated with TIPS. Acta Radiol 2000, 41:567-571.
142. Ortiz M., Córdoba J., Alonso J., et al. Oral glutamine challenge and magnetic resonance spectroscopy in three patients with congenital portosystemic shunts. J Hepatol 2004, 40:552-557.
143. 1H-MR spectra of alcohol-dependent and hepatic encephalopathy patients. Am J Psychiatry 1999, 156:952-954.
144. 1H magnetic resonance spectroscopy of hepatic encephalopathy. J Magn Reson Imaging 2005, 21:398-405.
145. Singhal A., Nagarajan R., Hinkin C.H., et al. Two-dimensional MR spectroscopy of minimal hepatic encephalopathy and neuropsychological correlates in vivo. J Magn Reson Imaging 2010, 32:35-43.
146. Sarma M.K., Huda A., Nagarajan R., et al. Multi-dimensional MR spectroscopy: Towards a better understanding of hepatic encephalopathy. Metab Brain Dis 2011, 26:173-184.
147. McConnell J.R., Antonson D.L., Ong C.S., et al. Proton spectroscopy of brain glutamine in acute liver failure. Hepatology 1995, 22:69-74.
148. 1H MR spectroscopy of the brain in children with acute liver failure. Eur Radiol 2008, 18:2601-2609.
149. 1H magnetic resonance spectroscopy-derived metabolite variations between acute-on-chronic liver failure and acute liver failure. Liver Int 2008, 28:1095-1103.
150. Foerster B.R., Conklin L.S., Petrou M., et al. Minimal hepatic encephalopathy in children: Evaluation with proton MR spectroscopy. Am J Neuroradiol 2009, 30:1610-1613.
151. Lockwood A.H., Yap E.W., Wong W.H. Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy. J Cereb Blood Flow Metab 1991, 11:337-341.
152. Cordoba J., Gottstein J., Blei A.T. Glutamine, myo-inositol, and organic brain osmolytes after portocaval anastomosis in the rat: Implications for ammonia-induced brain edema. Hepatology 1996, 24:919-923.
153. Taylor-Robinson S.D., Sargentoni J., Mallalieu R.J., et al. Cerebral phosphorus-31 magnetic resonance spectroscopy in patients with chronic hepatic encephalopathy. Hepatology 1994, 20:1173-1178.
154. Taylor-Robinson S.D., Sargentoni J., Oatridge A., et al. MR imaging and spectroscopy of the basal ganglia in chronic liver disease: Correlation of T1-weighted contrast measurements with abnormalities in proton and phosphorus-31 MR spectra. Metab Brain Dis 1996, 11:249-268.
155. Taylor-Robinson S.D., Buckley C., Changani K.K., et al. Cerebral proton and phosphorus-31 magnetic resonance spectroscopy in patients with subclinical hepatic encephalopathy. Liver 1999, 19:389-398.
156. Patel N., Forton D.M., Coutts G.A., et al. Intracellular pH measurements of the whole head and the basal ganglia in chronic liver disease: A phosphorus-31 MR spectroscopy study. Metab Brain Dis 2000, 15:223-240.
157. 31P magnetic resonance spectroscopy reveals osmotic and metabolic disturbances in human hepatic encephalopathy. J Neurochem 1998, 71:1564-1576.
158. Barbiroli B., Gaiani S., Lodi R., et al. Abnormal brain energy metabolism shown by in vivo phosphorus magnetic resonance spectroscopy in patients with chronic liver disease. Brain Res Bull 2002, 59:75-82.
159. Blüml S., Moreno-Torres A., Ross B.D. [1-13C]glucose MRS in chronic hepatic encephalopathy in man. Magn Reson Med 2001, 45:981-993.
160. Córdoba J. New assessment of hepatic encephalopathy. J Hepatol 2011, 54:1030-1040.
161. Cordoba J., Hinojosa C., Sampedro F., et al. Usefulness of magnetic resonance spectroscopy for diagnosis of hepatic encephalopathy in a patient with relapsing confusional syndrome. Dig Dis Sci 2001, 46:2451-2455.